GSK has licensed its shigella vaccine candidate to Bharat Biotech. The Big Pharma, which has vowed to help Bharat with trial design and fundraising, framed the deal as a way to get the vaccine to ...

GSK is continuing to bolster its siRNA portfolio by paying $40 million upfront for a pair of oligonucleotide therapies from China’s Frontier Biotechnologies. The companies didn’t offer many details ...

GSK said on Thursday that the US Food and Drug Administration has approved its drug ‘Lynavoy’, or linerixibat, for the ...

Add Yahoo as a preferred source to see more of our stories on Google. A GSK logo is seen on the side of an office building in Poznan, Poland. (Getty Images) This story was originally published on ...

GSK’s Lynavoy receives US FDA approval for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Saturday, March 21, 2026, 11:00 Hrs [IST] GSK plc announ ...

March 19 (Reuters) - The U.S. Food and Drug Administration approved GSK's drug for severe itching caused by a type of liver ...

GSK PLC on Thursday said the US Food & Drug Administration approved Lynavoy for the treatment of cholestatic pruritus in ...

With an increase in the antimicrobial resistance to therapies for gonorrhea, doctors have been left with fewer options to treat the sexually transmitted infection (STI), which strikes more an 80 ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. In a surprise, advisers to the Food and Drug Administration on Thursday ...

Following the Trump administration's plans to explore whether a widely available generic medication called leucovorin could cure autism, GSK (NYSE:GSK), which once manufactured and marketed the ...

Add Yahoo as a preferred source to see more of our stories on Google. A GSK logo is seen on the side of an office building in Poznan, Poland. As part of its fight against autism, the Trump ...